9020 POSTER DISCUSSION Use of Bevacizumab (BV) After Induction Therapy is Associated With Survival Benefit in Patients (pts) With Non-small Cell Lung Cancer (NSCLC) in the ARIES Observational Cohort Study (OCS)

✍ Scribed by Kostv, M.P.; Brahmer, J.R.; Jahanzeb, M.; Kumar, P.; Robles, R.; Wozniak, A.J.; Leon, L.; Flick, E.D.; Dalai, D.; Lynch, T.J.

• Book ID: 122864809
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 44 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)72332-2